- Home
- MG vs RCKT Comparison
MG vs RCKT Comparison
Compare MG & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MG
- RCKT
- Stock Information
- Founded
- MG 1978
- RCKT 1999
- Country
- MG United States
- RCKT United States
- Employees
- MG N/A
- RCKT N/A
- Industry
- MG Military/Government/Technical
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- MG Consumer Discretionary
- RCKT Health Care
- Exchange
- MG Nasdaq
- RCKT Nasdaq
- Market Cap
- MG 309.4M
- RCKT 340.9M
- IPO Year
- MG 2009
- RCKT N/A
- Fundamental
- Price
- MG $11.22
- RCKT $2.84
- Analyst Decision
- MG
- RCKT Buy
- Analyst Count
- MG 0
- RCKT 14
- Target Price
- MG N/A
- RCKT $29.12
- AVG Volume (30 Days)
- MG 158.7K
- RCKT 2.0M
- Earning Date
- MG 11-04-2025
- RCKT 11-06-2025
- Dividend Yield
- MG N/A
- RCKT N/A
- EPS Growth
- MG 60.33
- RCKT N/A
- EPS
- MG 0.57
- RCKT N/A
- Revenue
- MG $715,300,000.00
- RCKT N/A
- Revenue This Year
- MG $1.23
- RCKT N/A
- Revenue Next Year
- MG $2.80
- RCKT $3,582.16
- P/E Ratio
- MG $19.60
- RCKT N/A
- Revenue Growth
- MG N/A
- RCKT N/A
- 52 Week Low
- MG $7.06
- RCKT $2.19
- 52 Week High
- MG $13.43
- RCKT $15.01
- Technical
- Relative Strength Index (RSI)
- MG 51.13
- RCKT 32.29
- Support Level
- MG $12.50
- RCKT $2.85
- Resistance Level
- MG $13.43
- RCKT $3.37
- Average True Range (ATR)
- MG 0.60
- RCKT 0.20
- MACD
- MG -0.06
- RCKT -0.06
- Stochastic Oscillator
- MG 44.72
- RCKT 2.90
About MG Mistras Group Inc
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.